Company news
GemPharmatech Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
(688046)"GEMPHARMATECH CO., LTD."Report for Q3 2026
October 28, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Resolutions of the 2nd Meeting of the 3rd Board of Directors
October 28, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Provision for Asset Impairment for the First Three Quarters of 2026
October 28, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Expiration of the Lock-up Period and Satisfaction of Unlocking Conditions for the Reserved Grant under the 2025 Employee Stock Ownership Plan
October 28, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
October 28, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business License
October 28, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Capital Increase in Wholly-owned Subsidiaries
October 28, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
October 19, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Election of Employee Representative Director for the 3rd Board of Directors
October 19, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executives and Securities Affairs Representatives
October 19, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Appointment of Board Secretary
October 19, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026
October 15, 2026
(688046)"GEMPHARMATECH CO., LTD."Announcement on Public Solicitation of Voting Rights by CHINA SECURITIES INVESTOR SERVICES CENTER
October 8, 2026
Announcement on Resolutions of the 21st Meeting of the 2nd Board of Directors
September 30, 2026
Announcement on the Opening of a Dedicated Settlement Account for Wealth Management Products Purchased with Raised Funds
September 23, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 10, 2026
Indicative Announcement on the Report on Results of Shareholders' Inquiry-Based Transfer and Changes in Equity Interests of Shareholders Holding More Than 5% of Shares Reaching an Integral Multiple of 5%
September 2, 2026
Indicative Announcement on the Pricing of the Shareholder's Inquiry-based Transfer
August 25, 2026
Shareholder Inquiry Transfer Plan
August 24, 2026
Announcement on the Profit Distribution Proposal for the First Half of 2026
August 19, 2026
Announcement on Abnormal Fluctuations in Stock Trading
August 10, 2026
Announcement on the Vesting Results of the Third Vesting Period of the Initial Grant under the 2022 Restricted Share Incentive Plan and the Listing of the Shares
July 29, 2026
Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026
July 21, 2026
Announcement on Capital Increase in Joint-stock Company and Related Party Transactions
June 18, 2026
Announcement on Expiration of the Lock-up Period and Achievements of Unlocking Conditions for the Initial Grant Part of 2025 Employee Stock Ownership Plan
June 5, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 2, 2026
Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026
May 22, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 14, 2026
Announcement on Canceling Stock Appreciation Right under 2025 Stock Appreciation Right Incentive Plan
May 13, 2026
Announcement on Adding Partial Internal Corporate Governance Systems
April 22, 2026
Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management
April 3, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 3, 2026
Announcement on Share Repurchase by Joint-stock Company and Related Party Transactions
January 7, 2026
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
November 13, 2025
Announcement on Implementation Result of Shares Repurchase and Share Changes
October 29, 2025
Announcement on Completion of Non-trading Transfer of Reserved Shares under the 2025 Employee Stock Ownership Plan
October 27, 2025
GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery
October 22, 2025
Announcement on Electing Employee Representative Director of the 2nd Board of Directors
October 13, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
October 9, 2025
Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership Plan
September 29, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 25, 2025
Announcement on Cancelling Board of Supervisors, Amending the Articles of Association, Handling Industrial and Commercial Change Registration, and Revising and Formulating Some Corporate Governance Systems
August 22, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 4, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision
June 30, 2025
Announcement on Cancellation and Opening of Special Settlement Accounts for Raised Fund Financial Products
June 25, 2025
Announcement on Adjusting Total Cash Dividends for 2024 Annual Profit Distribution
June 6, 2025
Announcement on Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement for Raised Funds
June 5, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 28, 2025
Announcement on Granting Stock Appreciation Rights to Incentive Objects of 2025 Stock Appreciation Right Incentive Plan
May 23, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing
May 19, 2025